ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Aug. 28, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardelyx, Inc. (“Ardelyx” or “the Company”) (NASDAQ: ARDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act…

HeroDevs Announces Never-Ending Support for Spring – Ongoing Security and Compliance After Spring Framework 5.3, 6 End-of-Life

SANDY, Utah, Aug. 28, 2024 /PRNewswire/ — HeroDevs announces the launch of Never-Ending Support (NES) for Spring, a drop-in replacement designed to provide continuous security and compliance updates past Spring Framework’s upcoming end-of-life date. This initiative addresses the…

Refreshed. Recreated. Reimagined.

CTA® and CES® Introduce New Brand Mark and Website ARLINGTON, Va., Aug. 28, 2024 /PRNewswire/ — For the first time, the Consumer Technology Association (CTA)® and CES® are launching a shared brand identity. Also, CES.tech is transforming with a completely new design, offering an enhanced…

Asieris Pharmaceuticals Releases 2024 Semi-Annual Report, Highlighting Steady Progress in Launching Blockbuster Product for Precancerous Cervical Lesions and Continued Strengthening of Commercial Revenue Generation Capabilities

As of the date of this publication, APL-1702 has not been approved for the treatment of cervical high-grade squamous intraepithelial lesions (HSIL); APL-1706 has not been approved for the diagnosis or surgical treatment of bladder cancer in China. This article is intended to disclose the…

Keymed Biosciences annonce ses résultats intermédiaires pour le premier semestre 2024

CHENGDU, Chine, 28 août 2024 /PRNewswire/ — Keymed Biosciences Inc. (HKEX : 02162) a annoncé aujourd’hui ses résultats intermédiaires pour le premier semestre 2024, ainsi qu’une mise à jour corporative. Développement rapide de nos produits de pipeline Stapokibart (CM310) (anticorps…

Keymed Biosciences gibt Zwischenergebnisse für das erste Halbjahr 2024 bekannt

CHENGDU, China, 28. August 2024 /PRNewswire/ — Keymed Biosciences Inc. (HKEX: 02162) gab heute seine Zwischenergebnisse für das erste Halbjahr 2024 sowie ein Unternehmensupdate bekannt. Rasche Entwicklung unserer Produkte in der Pipeline Stapokibart (CM310) (IL-4Rα-Antikörper) Im Juni…

Socure Wins Datos Insights’ Fraud & AML Impact Award for Best Digital Identity Verification Innovation

Company Also Earns Silver Medal for Best Sanctions/Watchlist Screening Solution INCLINE VILLAGE, Nev., Aug. 28, 2024 /PRNewswire/ — Socure, the leading provider of artificial intelligence for digital identity verification, sanctions screening, and fraud prevention, today announced that…

Class Action Announcement for lululemon athletica inc. (LULU): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against lululemon athletica inc.

RADNOR, Pa., Aug. 28, 2024 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against lululemon athletica inc….

EXTR Investors Have Opportunity to Lead Extreme Networks, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Aug. 28, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Extreme Networks, Inc. (“Extreme Networks” or “the Company”) (NASDAQ: EXTR) for violations of §§10(b) and 20(a) of the…

AFS Logistics appoints Andy Dyer as new Chief Executive Officer

Industry veteran has a proven record of driving growth for 3PLs and optimizing and executing transportation networks SHREVEPORT, La., Aug. 28, 2024 /PRNewswire/ — AFS Logistics announces Andy Dyer as its new CEO. Dyer has more than a quarter of a century of supply chain and…